Literature DB >> 20825793

A pilot study on potential new plasma markers for diagnosis of acute appendicitis.

Geertje Thuijls1, Joep P M Derikx, Fred J Prakken, Bregje Huisman, Annemarie A van Bijnen Ing, Ernest L W E van Heurn, Wim A Buurman, Erik Heineman.   

Abstract

BACKGROUND: Diagnosis of acute appendicitis (AA) remains a surgical dilemma, with negative appendectomy rates of 5% to 40% and perforation suggestive for late operative intervention in 5% to 30%. The aim of this study is to evaluate new plasma markers, representing early neutrophil activation, to improve diagnostic accuracy in patients suspected for AA.
MATERIALS AND METHODS: Fifty-one patients who underwent surgery for AA were included (male-female = 28:23), and blood was sampled. Plasma concentrations of 2 neutrophil proteins were measured: lactoferrin (LF) and calprotectin (CP). Controls consisted of 27 healthy volunteers. C-reactive protein (CRP) and white blood cell count (WBC) concentrations were measured for routine patient care.
RESULTS: Median plasma concentrations for LF and CP were significantly higher in 51 patients with proven AA (665 and 766 ng/mL, respectively) than in 27 healthy volunteers (198 and 239 ng/mL, respectively, P < .001). No clinically relevant correlation exists between the plasma levels of LF and CP and the conventional laboratory tests for CRP and WBC.
CONCLUSIONS: Circulating LF and CP levels are significantly elevated in patients with appendicitis and are detectable in plasma using relatively simple and low-cost enzyme-linked immunosorbent assays. Furthermore, plasma levels of LF and CP give additional information to conventional markers WBC and CRP, making them potential new markers for AA diagnosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825793     DOI: 10.1016/j.ajem.2009.09.029

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

1.  The Place of Calprotectin, Lactoferrin, and High-Mobility Group Box 1 Protein on Diagnosis of Acute Appendicitis with Children.

Authors:  Sevgi Buyukbese Sarsu; Ayse Binnur Erbagci; Hasan Ulusal; Suleyman Cuneyt Karakus; Özlem Gümüstekin Bulbul
Journal:  Indian J Surg       Date:  2016-01-14       Impact factor: 0.656

Review 2.  The role of calprotectin in pediatric disease.

Authors:  George Vaos; Ioannis D Kostakis; Nick Zavras; Athanasios Chatzemichael
Journal:  Biomed Res Int       Date:  2013-09-23       Impact factor: 3.411

3.  Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men.

Authors:  Kim van Wijck; Kaatje Lenaerts; Luc J C van Loon; Wilbert H M Peters; Wim A Buurman; Cornelis H C Dejong
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

4.  Serum Procalcitonin and Lactoferrin in Detection of Acute Appendicitis; a Diagnostic Accuracy Study.

Authors:  Mohammad-Reza Motie; Anvar Soleimani; Arash Soltani; Seyed Isaac Hashemy
Journal:  Emerg (Tehran)       Date:  2018-08-25

5.  Elevated serum lactoferrin and neopterin are associated with postoperative infectious complications in patients with acute traumatic spinal cord injury.

Authors:  Ke Huang; Gang Du; Chengshou Wei; Song Gu; Jun Tang
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

6.  Plasma calprotectin level: usage in distinction of uncomplicated from complicated acute appendicitis.

Authors:  Murat Cikot; Kivanc Derya Peker; Mehmet Abdussamet Bozkurt; Ali Kocatas; Osman Kones; Sinan Binboga; Asuman Gedikbasi; Halil Alis
Journal:  World J Emerg Surg       Date:  2016-01-27       Impact factor: 5.469

7.  Diagnostic Accuracy of Serum and Urine S100A8/A9 and Serum Amyloid A in Probable Acute Abdominal Pain at Emergency Department.

Authors:  Arash Forouzan; Kambiz Masoumi; Fakher Rahim; Meisam Moezzi; Ali Khavanin; Nastaran Ranjbari; Malehi Amal Saki; Amirali Fallah Amoli; Niloofar Akhiani; Fatemeh Ghourchian
Journal:  Dis Markers       Date:  2018-07-03       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.